• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.37 número2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.37 número2"

Copied!
3
0
0

Texto

(1)

rev bras hematol hemoter. 2015;37(2):127–129

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Case

Report

Burkitt’s

lymphoma

successfully

treated

in

pregnancy

Alan

Lúcio

Alves

Inácio

Júnior

,

Beatriz

Fernandes

Rocha,

Luís

Fábio

Barbosa

Botelho

UniversidadeFederaldaParaíba(UFPB),JoãoPessoa,PB,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received9May2014 Accepted30June2014

Availableonline21November2014

Introduction

Neoplastic diseases affect about 1:1000 women during pregnancy.1Thisincidencevariesaccordingtoregion,ageand

thepresenceorabsenceofpre-invasivediseases.2

Lymphomais the fourth mostdiagnosed cancer inthis period,behindbreasttumors,cervicalcancerandmelanoma.3

Itsfrequencyhasrisenwiththetendencyinmodernsociety ofpostponingpregnancy.4

The most common lymphoma in pregnant patients is Hodgkin’s lymphoma, since its incidence spike coincides withthefemalefertile age.Anylinkbetweennon-Hodgkin lymphoma and pregnancy has still not been elucidated, withfewcasereportsbeingfoundinthemedicalliterature worldwide.3,4

Burkitt’slymphoma isa very aggressivegerminal B-cell lymphoma,frequentlypresentingextranodal sites.Itisthe secondmostcommonlymphomainchildren,butitisveryrare inadults.Threeclinicalvariantsareknown:endemic,sporadic andimmunodefficiency-related.5

Correspondingauthorat:UniversidadeFederaldaParaíba(UFPB),CampusI,JardimUniversitárioS/N,CasteloBranco,58051-900João

Pessoa,PB,Brazil.

E-mailaddress:[email protected](A.L.A.InácioJúnior).

Inthesporadicform,theprimarylocationofthedisease involves the abdomen in 80% and the mandible in14% of patients. In the endemicform, themandibular and maxil-laryareinvolvedin60%ofpatients,abdominalcommitment in58%ofcases,followedbythecentralandparaspinal ner-voussystems.Animportantgeographicdifferencebetween thesetwoformsistheassociationofEpstein–Barrvirus(EBV) withtheendemicform.However,only15–20%ofBurkitt’s lym-phomasseeninEuropeandintheUSAareassociatedwith EBV.ThefrequencyofthisassociationinSouthAmericaseems intermediateand,inBrazil,afrequencyof70%forEBV asso-ciatedwithBurkitt’slymphomahasbeenreported.5

Burkitt’s lymphoma was the first identified neoplasm whosepathogenesisinvolvedachromosomaltranslocationas demonstratedbymolecularbiology.Thismutationinvolvesa translocationbetweenthedistalpartofthelongarmof chro-mosome8andchromosome14[t(8;14)(q24;q32)].Asaresultof thisrearrangement,themycproto-oncogeneinchromosome 8istranslocatedtotheimmunoglobulinheavychainlocusin chromosome14.6

http://dx.doi.org/10.1016/j.bjhh.2014.11.002

(2)

128

revbrashematolhemoter.2015;37(2):127–129

Case

report

A 25-year-old female patient born in Santa Rita, state of Paraíbaconsultedwitha slightstingingabdominalpain in thelefthypochondriacandlumbarregions,associatedwith diarrhea and melena forthree months. The resultof a b-HCGtest,performedbecauseofamenorrhea,waspositive.The obstetricultrasonography(USG)revealedafour-weektwo-day pregnancy.Afteronemonth,therewasanincreaseinthepain, associatedwithnauseaandweightloss.AnewobstetricUSG, performedduring prenatal care,showed amorphologically normalfetus(12weeks),inadditiontorightcolonthickening inthemother,withanextensive(5.0cm×3.0cm)

vascular-izedhypoechogenicformationnexttothehepaticangle.The patientwasaskedtourgentlyseekagastroenterologist.

With significant worsening of the abdominal pain and acuteexacerbationofthecondition,thepatientwenttothe HospitalUniversitárioLauroWanderley,whereshewas admit-tedtoperformmoretests.Acomputertomographyshoweda softtissuemassintheupperthirdpartoftheabdomen,with air-fluidlevel,and dilationofanteriorintestinalloops with partialobstruction(Figures1and2).

A further abdominal USG revealed an extensive (10.6cm×5.4cm)echo-complexmassintheright

hypochon-drial region, with a heterogeneous aspect (solid/cystic). A colonoscopy revealed a vegetative lesion of about 15cm occupyingaround90%oftheintestinallumen.

Thepatientwassubmittedtoenterectomyand typhlec-tomy,inadditiontorightsegmentalcolectomywithprimary latero-lateralileocolonicanastomosis.Surgerywascompleted withoutcomplicationsandthepatientevolvedwellafterthe procedure,withoutcomplaintsofbleedingorpaininthelower abdomen. Anevaluationofthe fetal was madeconfirming preservedvitality.Thepatientwasprescribednatural proges-terone(400mg/day)inordertokeeptheuterusquiescent.

Themassremovedduringsurgerywassubmittedto anato-mopathologicalevaluationrevealingmediumandlargecell non-Hodgkin lymphoma. Immunohistochemistry identified

Figure1–Heterogeneousmassoccupyingalmostallofthe ascendingandtransversecoloniclumenwithdilationand signsofdistalobstruction.

Figure2–Softtissuemassintheupperthirdofthe abdomenwithair-fluidlevel,dilationoftheanterior intestinalloopsandpartialobstruction.

featuresofBurkitt’slymphoma.Afterdischarge,thepatient wasreferredforonco-hematologicalandobstetriccare.

Thestagingofthelymphomarevealedisolatedabdominal disease,withnobonemarroworcerebrospinalfluid involve-ment; it was classified as Murphy II-B. A 21-day regimen ofrituximab IV(375mg/m2 Day 1),cyclophosphamideIV

(500mg/m2 perdayDay 1–3),vincristineIV(2mgDay1

andDay8),doxorubicinIV(60mg/m2Day1),oralprednisone

(60mg/m2 Day 1–5) (COPAD-R) was started following the

LMB-96protocol.Moreover,prophylaxisofthecentralnervous systemwascarriedoutusingintrathecalchemotherapy: dexa-methasone(2mg)andmethotrexate(12mg–Day2andDay 5).7–9

The patient was advised about the aggressiveness of the condition and the possible risks to the fetus during chemotherapy, but chose not to interrupt pregnancy. The patienthadagoodevolutionwithclinicalimprovement.

Duringobstetriccare,anothermorphologicalobstetricUSG revealed anon-ectopic pregnancywith anechographic age of 19.1 weeks – in addition to an abdominal USG, which showedasolidabdominalmass(8.6cm×10.8cm)inamedial

and slightly left position, which was heterogeneous with irregularedges.AnUSGperformedthefollowingweekshowed anon-ectopicpregnancywithechographicageof20.3weeks and preserved fetal morphology, and a solid abdominal mass(6.6cm×3.6cm×5.0cm),identicaltotheonepreviously

described,indicatingthattherewasadecreaseinsizeafterthe beginningofchemotherapy.

Afterfourcyclesofchemotherapy,thepatientevolvedwith anewacuteabdominalcondition.Laparotomyshoweda per-forationintheproximaljejunum,andsoanotherenterectomy andurgentcaesariansection(33rdweekofpregnancy)were performed. Ahealthy female childof1815gwas delivered. Thesegmentremovedinthesecond enterectomywassent foranatomopathologicalstudy,whichshowednodisease.A computertomographyafterbirthwasnormal.

(3)

revbrashematolhemoter.2015;37(2):127–129

129

Discussion

Burkitt’s lymphoma, although very aggressive, is highly treatable.10 The objective of treatment is to eliminate the

largestnumberofmalignantcellspossibleandinduce com-plete remission, in other words, the disappearance of all evidence of the disease. Patients with aggressive and fast growing lymphomasare frequently treatedwith combined chemotherapy.Intensivechemotherapywithmultipledrugs may be very effective against aggressive lymphomas. The prognosisofBurkitt’slymphomadependsontheextentofthe diseaseandthetimeintervalbetweenthefirstcomplaintsand diagnosis.Thedisease-freesurvivalrateisbetween75%and 85%inadults.6

There is no unique option for chemotherapeutic treat-mentofthiskindoflymphoma.Today,thechemotherapeutic treatmentconsistsinshort-durationintensiveregimensthat includeagentssuchasmethotrexate,cyclophosphamide, vin-cristine,doxorubicinandprednisone.Methotrexateisusedin mostofthebigcenters,butitishighlytoxicandis respon-sibleformostoftheriskduringpregnancy.Thetreatmentis complementedwithprophylaxisforinfections.Relapse some-timesoccursduringthefirstyear,andisaparticularlypoor prognosticsign.11

Thetreatmentofapregnantwomanwithcancerisalways adelicatedecision,sinceitinvolvesrisksforthemotherand child,thewishesofthepatientandtheopinionsofthe oncol-ogist,theobstetricianand the neonatologist.Thepotential effectsofantineoplasticagentstothefetusinclude immedi-ateeffects,suchasabortionandteratogenesiswithspecific damagetooneormoreorgans,andlateeffects,suchasdelay ingrowthandgonadaldysfunction.1

ThechoiceoftheCOPAD-RregimenfollowingtheLMB-96 protocol,7–9aimingatgreaterpracticalitywithfewerrisksfor

thepatient, wasverysuccessful,ensuringremissionofthe diseaseandcompletionofthepregnancy.

Therareoccurrenceoflymphomaduringpregnancy pre-ventslargeprospectivestudiesbeingperformedtoexamine issuesaboutdiagnosis,managementandtheoutcomes.The literatureaboutthesubjectispoorandbasedonretrospective analysis,andsofurtherstudiesarenecessary.

Conclusion

Theassociationofcancerandpregnancyisaveryrare con-dition.Duringalongtime,the occurrenceofcancerduring

pregnancy wasrelatedtotheideaofaveryaggressive dis-ease,withreservedprognosisandlittleperspectivetotreat. However,recently,therehavebeenreportsofcasesinwhich chemotherapywassuccessfullyusedinpregnantwomen.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.SchunemannEJr,UrbanCA,LimaRS,RabinovichI,Spautz CC.Radioterapiaequimioterapianotratamentodocâncer duranteagestac¸ão–revisãodeliteratura.RevBrasCancerol. 2007;53(1):41–6.

2.AtallaAA,HallackNetoAE,RianiLR,SoaresGM,MirandaMA, GomideBO,etal.LinfomadeHodgkinegestac¸ão.Relatode casoerevisãodeliteratura.RevBrasClinMed.

2010;8(3):276–82.

3.KassabC,PeriniGF,BollmannPW,KerbauyFR,Hamerschlak N.LinfomadeHodgkinegestac¸ão:sériedecasoseproposta deprotocoloparatratamento.Einstein.2011;92Pt1:216–9.

4.PeregD,KorenG,LishnerM.ThetreatmentofHodgkin’sand non-Hodgkin’slymphomainpregnancy.Haematologica. 2007;92(9):1230–7.

5.KlumbCE.BiologiaepatogênesedoslinfomasnãoHodgkinde origemBnaInfância.RevBrasCancerol.2001;43(3):291–301.

6.AfanasN,CarvalhoM,AlmeidaM,CostaV,SilvaI,OlivaT. LinfomadeBurkittempediatria.ActaMedPort.

2011;24(5):735–8.

7.ChoiMK,JunHJ,LeeSY,KimKH,LimdoH,KimK,etal. TreatmentoutcomeofadultpatientswithBurkittlymphoma: resultsusingtheLMBprotocolinKorea.AnnHematol. 2009;88(11):1099–106.

8.MadaniA,BenhmiddouneL,ZafasS,HarifM,QuessarA, BenchekrounS.TreatmentofchildhoodBurkittlymphoma accordingtoLMB89protocolinCasablanca.BullCancer. 2005;92(2):193–8.

9.GerrardM,CairoMS,WestonC,AuperinA,PinkertonR, LambillioteA,etal.Excellentsurvivalfollowingtwocourses ofCOPADchemotherapyinchildrenandadolescentswith resectedlocalizedB-cellnon-Hodgkin’slymphoma:resultsof theFAB/LMB96internationalstudy.BrJHaematol.

2008;141(6):840–7.

10.TorricelliFC,LopesRI,DiasAR,MarchiniGS,BonaféWW, LopesJM,etal.Linfomailealprimáriocomoumacausade intussuscepc¸ãoileocecalrecorrente.RevBrasColoproct. 2008;28(2):246–50.

Imagem

Figure 1 – Heterogeneous mass occupying almost all of the ascending and transverse colonic lumen with dilation and signs of distal obstruction.

Referências

Documentos relacionados

Methods: Flow cytometry analysis of circulating endothelial cells was performed applying three different panels composed of different combinations of the CD144, CD146, CD31, CD133,

This population sample includes patients with clinical suspicion of hemoglobinopathies and their family members, randomly chosen individuals who had blood tests and blood donors

Table 5 – The hypothetical hemoglobin concentration for poor performance status and hematopoietic cell transplantation-comorbidity index of patients with myeloid neoplasms.

The most common hematological abnormality of the SLE classification criteria in a cohort of Brazilian SLE patients was leukopenia followed by thrombocytopenia, lymphopenia and

Hemoglobin D-Punjab can be inherited in heterozygosis with hemoglobin A causing no clinical or hematological alterations, or in homozygosis, the rarest form of inheritance, a

Heterogeneous geographic distribution of human T cell lymphotropic viruses I and II (HTLV1/2): serological screening prevalence rates in blood donors from large urban areas in

5 Thus, due to differential treatment, the aim of this study was to report a case of hairy cell leukemia variant and cover some aspects related to the differential diagnosis between

Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Hommes DW, Duijvestein M,